EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.3.2.33 | Colonic Neoplasms |
30318507 |
Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers. |
diagnostic usage
unassigned |
2
0 |
| 2.3.2.33 | Hyperalgesia |
21098484 |
The ubiquitin ligase MYCBP2 regulates transient receptor potential vanilloid receptor 1 (TRPV1) internalization through inhibition of p38 MAPK signaling. |
therapeutic application
unassigned |
2
0 |
| 2.3.2.33 | Hyperalgesia |
26304119 |
MYCBP2 Is a Guanosine Exchange Factor for Ran Protein and Determines Its Localization in Neurons of Dorsal Root Ganglia. |
unassigned |
0 |
| 2.3.2.33 | Infections |
27224013 |
A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV. |
unassigned |
0 |
| 2.3.2.33 | Melanoma |
27620505 |
miR-92a-3p and MYCBP2 are involved in MS-275-induced and c-myc-mediated TRAIL-sensitivity in melanoma cells. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 2.3.2.33 | Neoplasms |
30318507 |
Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers. |
diagnostic usage
unassigned |
2
0 |
| 2.3.2.33 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
26517351 |
Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
2
3
0 |
| 2.3.2.33 | Prostatic Neoplasms |
25731699 |
MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2. |
unassigned |
0 |
| 2.3.2.33 | Virus Diseases |
27224013 |
A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV. |
unassigned |
0 |
